InvestorsHub Logo
Followers 80
Posts 24704
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Wednesday, 04/18/2018 8:00:06 AM

Wednesday, April 18, 2018 8:00:06 AM

Post# of 27623
RIGL - 4.11 Pre-market now at 4.43/4.44

Rigel Gets FDA Approval of Tavalisse for Chronic Immune Thrombocytopenia in Adult Patients





Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.